← Mechanisms of action
NGF
SINGLE PROTEINHomo sapiens
Preferred name: Beta-nerve growth factor ChEMBL ↗
Linked proteins
Drugs acting on this target (19)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| paliroden | Activator | experimental | Small molecule | NGF activator |
| 9.2.27 | Antagonist | experimental | mAb | NGF |
| ak115 | Antagonist | experimental | mAb | NGF |
| E1K | Antagonist | experimental | Peptide | NGF antagonist |
| ep-9001a | Antagonist | experimental | mAb | NGF |
| asp6282 | Inhibitor | experimental | mAb | NGF inhibitor |
| asp6294 | Inhibitor | experimental | mAb | NGF inhibitor |
| fasinumab | Inhibitor | experimental | mAb | NGF inhibitor |
| fulranumab | Inhibitor | experimental | mAb | NGF inhibitor |
| medi-578 | Inhibitor | experimental | mAb | NGF inhibitor |
| medi7352 | Inhibitor | experimental | mAb | NGF inhibitor |
| pg110 | Inhibitor | experimental | mAb | NGF inhibitor |
| sss40 | Inhibitor | experimental | Small molecule | NGF inhibitor |
| tanezumab | Inhibitor | experimental | mAb | NGF inhibitor |
| leteprinim | Modulator | experimental | Small molecule | NGF modulator |
| cere-110 | Supplementation | experimental | Gene therapy | NGF supplementation |
| kb801 | Supplementation | experimental | Gene therapy | NGF supplementation |
| ngf4-b | Supplementation | experimental | Recombinant protein | NGF supplementation |
| udonitrectag | Supplementation | experimental | Small molecule | NGF supplementation |